The Middle East & Africa non-invasive ventilation masks market was valued at US$ 60.54 million in 2023 and is expected to reach US$ 92.61 million by 2031; it is estimated to register a CAGR of 5.5% from 2023 to 2031.
Technological innovations are enhancing patient experience, improving design, and driving functionality. Patient compatibility is due to technological advancements, such as cushioning effects that allow patients to modify the shape of their nasal bridges. As a result, a customized fit ensures ideal contact and distributes pressure applied to the skin, thereby significantly reducing the likelihood of skin breakdown and associated complications. For instance, NIV masks are frequently needed by patients in hospital and intensive care unit settings to support their respiratory needs. Although these masks are essential for patient care, they can occasionally cause skin irritations and discomfort, especially in the area surrounding the nasal bridge. One of the leading medical device manufacturers, Sleepnet, created the ground-breaking AIR°gel technology to solve these issues. Every Sleepnet mask uses AIR°gel, which lessens skin breakdown and gives patients more comfort and protection. Notable NIV mask products that use these advancements include VariFit and Evora.
These developments in NIV masks meet the patients' requirements and improve effectiveness, comfort, and overall results while wearing the masks.
The Middle East and Africa noninvasive ventilation masks market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East and Africa. In the Middle East, the high prevalence of obesity, smoking, and diabetes play a significant role in propelling the prevalence of OSA. The market in the Middle East and Africa is driven by the rising prevalence of respiratory disorders, including COPD and OSA, as well as the increasing focus of hospitals on the usage of advanced methods, such as NIV masks, and adoption of growth strategies by the market players operating in the region. For instance, in August 2020, The Health Bank (THB) Global, a tech-enabled global health management company, partnered with the US-based companies Subsalve and Nanotronics Health, LLC, to bring NIV kits to the Middle East, North Africa, and South Asia (MENASA) region.
Strategic insights for the Middle East & Africa Non-Invasive Ventilation Masks provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 60.54 Million |
Market Size by 2031 | US$ 92.61 Million |
Global CAGR (2023 - 2031) | 5.5% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Product
|
Regions and Countries Covered | Middle East and Africa
|
Market leaders and key company profiles |
The geographic scope of the Middle East & Africa Non-Invasive Ventilation Masks refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Middle East & Africa non-invasive ventilation masks market is categorized into product, application, end user, and country.
By product, the Middle East & Africa non-invasive ventilation masks market is bifurcated into noninvasive ventilation disposable mask and noninvasive ventilation reusable mask. The noninvasive ventilation disposable mask segment held a larger share of the Middle East & Africa non-invasive ventilation masks market share in 2023.
In terms of application, the Middle East & Africa non-invasive ventilation masks market is segmented into sleep apnea, chronic obstructive pulmonary disease, pneumonia, and others. The sleep apnea segment held the largest share of the Middle East & Africa non-invasive ventilation masks market share in 2023.
Based on end user, the Middle East & Africa non-invasive ventilation masks market is segmented into hospitals and clinics, home care, and others. The hospitals and clinics segment held the largest share of the Middle East & Africa non-invasive ventilation masks market share in 2023.
Based on country, the Middle East & Africa non-invasive ventilation masks market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Saudi Arabia segment held the largest share of Middle East & Africa non-invasive ventilation masks market in 2023.
Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar S.P.A.; Dragerwerk AG & Co KGaA; Fisher & Paykel Healthcare Corp Ltd; Hamilton Medical AG; Hangzhou Formed Medical Devices Co., Ltd; Intersurgical Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC ( AirLife); and SURU INTERNATIONAL PVT. LTD. are some of the leading companies operating in the Middle East & Africa non-invasive ventilation masks market.
The Middle East & Africa Non-Invasive Ventilation Masks Market is valued at US$ 60.54 Million in 2023, it is projected to reach US$ 92.61 Million by 2031.
As per our report Middle East & Africa Non-Invasive Ventilation Masks Market, the market size is valued at US$ 60.54 Million in 2023, projecting it to reach US$ 92.61 Million by 2031. This translates to a CAGR of approximately 5.5% during the forecast period.
The Middle East & Africa Non-Invasive Ventilation Masks Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Non-Invasive Ventilation Masks Market report:
The Middle East & Africa Non-Invasive Ventilation Masks Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Non-Invasive Ventilation Masks Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Non-Invasive Ventilation Masks Market value chain can benefit from the information contained in a comprehensive market report.